title: [Interactions of cardiac and antiretroviral medication].
abstract: New therapeutic options such as the highly active antiretroviral therapy (HAART) have significantly improved morbidity and mortality of HIV-infected patients. Consequently, age-related diseases become more manifest. In addition, HIV infection itself causes certain cardiovascular morbidity. Therefore, treatment of cardiovascular symptoms of HIV-positive patients becomes more and more important. Pharmacotherapy in these patients is complex and requires polypharmacy with drugs carrying a high risk of drug-drug interactions.
authors.affiliation: Abteilung für Klinische Pharmakologie & Toxikologie, Universitätsspital, Basel, Schweiz.
authors.forename: Sabin
authors.initials: S
authors.lastname: Egger
authors.forename: Jürgen
authors.initials: J
authors.lastname: Drewe
mesh_terms: D044966:Anti-Retroviral Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000209:etiology*; D002986:Clinical Trials as Topic; D004347:Drug Interactions; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'
chemical_list: D044966:Anti-Retroviral Agents; D002317:Cardiovascular Agents